// App-Quantinova.ai

PB1093 : Diagnostic Potential of Rapid Automated ADAMTS13 Inhibitor Screening and Quantification

Researchers

Presenter

  • G. Moore

Principal Investigators

  • M. Griffiths

  • N. Binder

Medical Centers

  • Cambridge University Hospitals, Bexley, England, United Kingdom

  • Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria

Locations

  • United Kingdom

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • DNA methyltransferase 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A